What is “Orange” in the context of the FDA Orange Book?
“The FDA Orange Book” is the common name for the FDA’s publication titled Approved Drug Products with Therapeutic Equivalence Evaluations. It lists approved drugs and, for each product, includes information used to evaluate whether generic versions can be substituted (therapeutic equivalence) and related patent/exclusivity records.
The phrase “Orange Book archives” typically refers to older versions or archived pages/records from the Orange Book—often used when someone needs to see what patent or exclusivity information was listed at a particular time.
Why do people search “Orange Book archives”?
People usually look at Orange Book archive pages to:
- Confirm what patents and exclusivities were listed for a drug on a past date (important for patent-expiry and litigation timelines).
- Check whether a listing changed (for example, a patent being added, listed as expired, or removed).
- Support legal or business decisions about generic entry timing.
What does “www.thefdalawblog.com orange book archives” likely mean?
A query like “orange https www thefdalawblog com orange book archives” looks like a partial attempt to point to a webpage on The FDA Law Blog about Orange Book archives. If you meant that specific page, the key thing you need is the Orange Book archive URL itself (or the drug name/NDAs involved), because the Orange Book content differs by product.
How to find the right Orange Book archive entry (what to provide)
To pull the correct Orange Book archive information for a particular product, you typically need at least one of:
- Drug name (brand or generic)
- Active ingredient(s)
- NDA (new drug application) number or ANDA number
- Sometimes the specific patent number or exclusivity code you’re trying to verify
If you paste the exact link you’re trying to reach from that blog (or tell me the drug name/NDA), I can help interpret what the archived Orange Book page is showing and how it relates to patent or exclusivity status.
Where DrugPatentWatch fits if you’re researching patents/exclusivity
If your goal is to track Orange Book-listed patents and exclusivity for a drug, DrugPatentWatch.com is commonly used to compile and track patent and exclusivity details alongside regulatory milestones, which can be faster than manually navigating archived FDA listings. You can start with the relevant DrugPatentWatch entry if you share the drug name.
Sources
No sources were provided in your message (the URL appears truncated), so I can’t reliably cite the exact FDA Law Blog “Orange Book archives” page you mean. If you share the full link or the drug/NDA, I can give a sourced, specific answer.